CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
about
Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspectiveRenal Cancer Stem Cells: Characterization and Targeted TherapiesCurrent approaches in identification and isolation of human renal cell carcinoma cancer stem cellsTargeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem CellsComparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer CellsCXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.Downregulation of UHRF1 increases tumor malignancy by activating the CXCR4/AKT-JNK/IL-6/Snail signaling axis in hepatocellular carcinoma cells.Metastasis-Initiating Cells in Renal Cancer.PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway.Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinomaFunctional significance of CD105-positive cells in papillary renal cell carcinoma.Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancerThe Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis.Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivityEmerging targets in cancer management: role of the CXCL12/CXCR4 axis.C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.Emerging role of mucins in epithelial to mesenchymal transition.Concise reviews: cancer stem cells: from concept to cure.Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets.Gene set enrichment analysis and ingenuity pathway analysis of metastatic clear cell renal cell carcinoma cell line.HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma.BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.Cancer stem cell marker glycosylation: Nature, function and significance.A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization.Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma.Targeting HIF2 in Clear Cell Renal Cell Carcinoma.Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases.Biomarker discovery for renal cancer stem cells.Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal Cancer.
P2860
Q26744089-F47D431C-7A79-43FA-B3A7-9AD34959527CQ26746970-AEA0728D-C10A-45CE-A22D-FE2D0A549406Q26786047-FB5161D1-38CF-4BE1-8404-359806092511Q28078154-7525BCD2-CE3C-4F8F-B3BF-8FBAE763593FQ28553202-92F1F46A-DD21-4C77-8AD1-80073F16EB04Q33677057-2A235E08-3826-43BE-80A7-26714D077BB9Q33761985-D61217B3-10F3-4CAA-BF51-DFD2DDE0D641Q33765984-A559ACE7-42EB-4691-A4CF-D24340BDACD7Q34077268-57011F79-7295-4539-9D98-C368B0DEAF59Q35165755-14C3D837-541C-4E13-A12E-0280D5A71004Q35213463-9925101D-E29D-455D-8C26-389D0DC051EDQ35677757-7FFB30EF-4F79-4F2F-A5B6-EA74FFB3AD2EQ36241043-98D8D26B-FDB1-404F-940D-2AB8A9D57C0EQ36293646-B766EEFD-D537-47C7-9ACE-5457261B5077Q36300487-3D88DA50-64F1-441C-A0F5-9F35876D6F10Q36382520-BE759230-6910-4395-A6A6-80ADEC2033E9Q37225329-10B3C1AF-D49E-4096-88F0-C1B9F5E5B87BQ37564471-D7AE6645-3444-4841-88C5-B18BFE101359Q37584296-66297665-EBA1-4CD7-A7A5-28EFCC46BB14Q38235552-72D778CF-95DE-4D41-AF45-B20F1EC17EF4Q38264616-4B565EA2-323A-40C0-9360-72C9A2CCD919Q38712909-B66388EF-B6B1-4AB6-969F-235F0E89E8B6Q38763251-C8ACC19F-4BC5-4CC2-8403-DF919CC9723EQ38765612-2AC05750-AA84-4330-9F05-E129659DF3FFQ38830081-2653F3F1-6D24-47CE-9404-59A84704717BQ38937195-DEE35F33-BECC-4294-8E9E-6CC5D28493D8Q39380552-B3A48CC8-4558-485F-9B23-66219D5AAD9EQ41187419-49D3EFE7-542D-400A-B07E-FC73130296A3Q42320212-09B41B70-8947-4D83-86EC-62FBEBF4A16DQ46106579-50E45730-4D41-4286-862D-7255BD90DAE4Q47118235-B3155C1B-11D7-4A3E-9AE9-0D44273F8A81Q47432809-40482239-81CB-4777-B8AE-058B0C081F0BQ47611824-22A90713-1FF6-423B-B103-6E42F43B7139Q50027179-05A680E3-9FE7-453F-A8BD-6176A713143DQ50049701-F38FED9B-9118-4C35-8962-E69A0CF62DCBQ51496684-DD32D224-435F-499E-833D-62A58E082B8CQ55419613-922BD2B0-CEA6-422C-9823-8668BED9D36C
P2860
CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
CXC chemokine receptor 4 is es ...... cells and predicts metastasis.
@en
CXC chemokine receptor 4 is es ...... cells and predicts metastasis.
@nl
type
label
CXC chemokine receptor 4 is es ...... cells and predicts metastasis.
@en
CXC chemokine receptor 4 is es ...... cells and predicts metastasis.
@nl
prefLabel
CXC chemokine receptor 4 is es ...... cells and predicts metastasis.
@en
CXC chemokine receptor 4 is es ...... cells and predicts metastasis.
@nl
P2093
P2860
P356
P1433
P1476
CXC chemokine receptor 4 is es ...... cells and predicts metastasis
@en
P2093
Brigitte Mack
Dolores J Schendel
Heike Pohla
Lynette Henkel
Matthias Schiemann
Maximilian Gassenmaier
Wolfgang Zimmermann
P2860
P304
P356
10.1002/STEM.1407
P577
2013-08-01T00:00:00Z